title: Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.
abstract: BACKGROUND
  LIM and SH3 protein 1 (LASP-1) is a nucleo-cytoplasmatic signalling protein involved in cell proliferation and migration and is upregulated in breast cancer in vitro studies have shown that LASP-1 might be regulated by prostate-derived ETS factor (PDEF), p53 and/or LASP1 gene amplification. This current study analysed the prognostic significance of LASP-1 on overall survival (OS) in 177 breast cancer patients and addressed the suggested mechanisms of LASP-1-regulation.
  
  
  METHODS
  Nucleo-cytoplasmatic LASP-1-positivity of breast carcinoma samples was correlated with long-term survival, clinicopathological parameters, Ki67-positivity and PDEF expression. Rate of LASP1 amplification was determined in micro-dissected primary breast cancer cells using quantitative RT-PCR. Cell-phase dependency of nuclear LASP-1-localisation was studied in synchronised cells. In addition, LASP-1, PDEF and p53 expression was compared in cell lines of different tumour entities to define principles for LASP-1-regulation.
  
  
  RESULTS
  We showed that LASP-1 overexpression is not due to LASP1 gene amplification. Moreover, no correlation between p53-mutations or PDEF-expression and LASP-1-status was observed. However, nuclear LASP-1-localisation in breast carcinomas is increased during proliferation with peak in G2/M-phase and correlated significantly with Ki67-positivity and poor OS.
  
  
  CONCLUSIONS
  Our results provide evidence that nuclear LASP-1-positivity may serve as a negative prognostic indicator for long-term survival of breast cancer patients.
authors.affiliation: Institute for Clinical Biochemistry and Pathobiochemistry, University of Wuerzburg, Grombuehlstr. 12, 97080 Wuerzburg, Germany.
authors.forename: J J
authors.initials: JJ
authors.lastname: Frietsch
authors.forename: T G P
authors.initials: TG
authors.lastname: Grunewald
authors.forename: S
authors.initials: S
authors.lastname: Jasper
authors.forename: U
authors.initials: U
authors.lastname: Kammerer
authors.forename: S
authors.initials: S
authors.lastname: Herterich
authors.forename: M
authors.initials: M
authors.lastname: Kapp
authors.forename: A
authors.initials: A
authors.lastname: Honig
authors.forename: E
authors.initials: E
authors.lastname: Butt
mesh_terms: D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism / Q000401:mortality*; D002277:Carcinoma / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism / Q000401:mortality*; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005784:Gene Amplification / Q000502:physiology; D006801:Humans; D060588:LIM Domain Proteins; D008875:Middle Aged; D011379:Prognosis; D016019:Survival Analysis; D017741:Survivors / Q000706:statistics & numerical data; D013997:Time Factors; D014018:Tissue Distribution
chemical_list: D048868:Adaptor Proteins, Signal Transducing; D003598:Cytoskeletal Proteins; C096353:LASP1 protein, human; D060588:LIM Domain Proteins
references.citation: Methods Mol Biol. 2000;132:365-86
references.pmid: 10547847
references.citation: J Biol Chem. 2003 May 2;278(18):15601-7
references.pmid: 12571245
references.citation: FEBS Lett. 2006 May 29;580(13):3223-8
references.pmid: 16697374
references.citation: Breast Cancer Res Treat. 2007 Mar;102(1):19-30
references.pmid: 16897429
references.citation: J Cell Sci. 2002 Dec 15;115(Pt 24):4787-99
references.pmid: 12432067
references.citation: Biochem Biophys Res Commun. 2004 Nov 5;324(1):308-16
references.pmid: 15465019
references.citation: J Biol Chem. 2004 May 7;279(19):20401-10
references.pmid: 15004028
references.citation: FEBS Lett. 1995 Oct 16;373(3):245-9
references.pmid: 7589475
references.citation: BMC Cancer. 2007 Oct 23;7:198
references.pmid: 17956604
references.citation: Trends Cell Biol. 2005 Mar;15(3):121-4
references.pmid: 15752974
references.citation: Mol Cancer. 2008 Apr 17;7:31
references.pmid: 18419822
references.citation: Mol Med. 1998 Oct;4(10):675-87
references.pmid: 9848085
references.citation: Br J Cancer. 2007 Jan 29;96(2):296-305
references.pmid: 17211471
references.citation: Hum Pathol. 2007 Nov;38(11):1628-38
references.pmid: 17521701
references.citation: Genomics. 1995 Aug 10;28(3):367-76
references.pmid: 7490069
references.citation: Mod Pathol. 2005 Mar;18(3):374-81
references.pmid: 15578079
references.citation: Int J Biochem Cell Biol. 2007;39(7-8):1375-87
references.pmid: 17543572
references.citation: CA Cancer J Clin. 2006 Jan-Feb;56(1):37-47; quiz 50-1
references.pmid: 16449185
references.citation: J Orthop Res. 2006 Nov;24(11):2059-71
references.pmid: 16947300
references.citation: Bioessays. 1997 Nov;19(11):949-57
references.pmid: 9394617
references.citation: Cancer Res. 1996 Sep 1;56(17):3886-90
references.pmid: 8752152
references.citation: Cancer Res. 2003 Aug 1;63(15):4626-31
references.pmid: 12907642
references.citation: Breast. 2005 Dec;14(6):617-23
references.pmid: 16169224
references.citation: J Mol Diagn. 2001 Feb;3(1):22-5
references.pmid: 11227068
references.citation: Transl Oncol. 2009 Aug 18;2(3):107-16
references.pmid: 19701494
references.citation: Methods. 2001 Dec;25(4):409-18
references.pmid: 11846610
references.citation: Neoplasia. 2007 Oct;9(10):788-96
references.pmid: 17971898
references.citation: Neoplasia. 2009 Feb;11(2):207-19
references.pmid: 19177205
references.citation: Mod Pathol. 2000 Jul;13(7):730-5
references.pmid: 10912931
references.citation: Tumori. 2009 May-Jun;95(3):357-66
references.pmid: 19688977
references.citation: Exp Cell Res. 2006 Apr 15;312(7):974-82
references.pmid: 16430883
references.citation: Semin Cancer Biol. 1999 Apr;9(2):125-38
references.pmid: 10202134
references.citation: J Biol Chem. 2003 Jan 24;278(4):2157-68
references.pmid: 12441356
references.citation: Nat Rev Mol Cell Biol. 2004 Nov;5(11):920-31
references.pmid: 15520811
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: J Hepatol. 2009 Mar;50(3):528-37
references.pmid: 19155088
references.citation: J Cell Biol. 2000 May 29;149(5):1073-86
references.pmid: 10831611
references.citation: Biochemistry. 1996 Oct 1;35(39):12723-32
references.pmid: 8841116
references.citation: Mol Biol Cell. 2008 Sep;19(9):3745-57
references.pmid: 18579687
references.citation: J Mol Diagn. 2000 May;2(2):84-91
references.pmid: 11272893
references.citation: Pathologe. 1987 May;8(3):138-40
references.pmid: 3303008
references.citation: Genes Chromosomes Cancer. 1994 Aug;10(4):231-43
references.pmid: 7522536
references.citation: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references.pmid: 17237035
references.citation: Oncogene. 2006 Jun 29;25(28):3994-4008
references.pmid: 16491124
references.citation: Cancer Res. 2008 Oct 15;68(20):8499-506
references.pmid: 18922924